SEC Form 4 · accession 0001225208-18-004962
HARTFORD INSURANCE GROUP, INC. · HIG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Beth Ann Bombara
Officer — EVP and CFO
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 5:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874766
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2018 | M | 16,938 | $24.15 | A | 61,731 | D | |
| Common Stock | Feb 27, 2018 | M | 4,368 | $28.91 | A | 66,099 | D | |
| Common Stock | Feb 27, 2018 | M | 2,399 | $20.63 | A | 68,498 | D | |
| Common Stock | Feb 27, 2018 | M | 200 | $24.15 | A | 68,698 | D | |
| Common StockF2 | Feb 27, 2018 | S | 200 | $54.83 | D | 68,498 | D | |
| Common StockF3 | Feb 27, 2018 | S | 2,399 | $54.231 | D | 66,099 | D | |
| Common StockF4 | Feb 27, 2018 | S | 4,368 | $54.246 | D | 61,731 | D | |
| Common StockF6 | Feb 27, 2018 | F | 9,640 | $53.95 | D | 52,091 | D | |
| Common StockF7 | Feb 27, 2018 | S | 16,938 | $54.238 | D | 35,153 | D | |
| Restricted Stock Units | holding | — | — | — | 18,940 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF8 | $53.81 | Feb 27, 2018 | A | 63,194 | A | — | Feb 27, 2028 | Common Stock | 63,194 | 63,194 | D |
| Stock OptionF9 | $20.63 | Feb 27, 2018 | M | 2,399 | D | — | Feb 28, 2022 | Common Stock | 2,399 | 4,799 | D |
| Stock OptionF10 | $28.91 | Feb 27, 2018 | M | 4,368 | D | — | Mar 1, 2021 | Common Stock | 4,368 | 8,736 | D |
| Stock OptionF11 | $24.15 | Feb 27, 2018 | M | 200 | D | — | Mar 5, 2023 | Common Stock | 200 | 51,214 | D |
| Stock OptionF11 | $24.15 | Feb 27, 2018 | M | 16,938 | D | — | Mar 5, 2023 | Common Stock | 16,938 | 34,276 | D |
| Stock OptionF12 | $35.83 | holding | — | — | — | — | Mar 4, 2024 | Common Stock | 47,214 | 47,214 | D |
| Stock OptionF13 | $41.25 | holding | — | — | — | — | Mar 3, 2025 | Common Stock | 77,830 | 77,830 | D |
| Stock OptionF14 | $43.59 | holding | — | — | — | — | Mar 1, 2026 | Common Stock | 72,076 | 72,076 | D |
| Stock OptionF15 | $48.89 | holding | — | — | — | — | Feb 28, 2027 | Common Stock | 70,679 | 70,679 | D |
Explanation of responses
- F1Transaction effected pursuant to a pre-planned trading plan entered into on December 12, 2017 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F10The options became fully exercisable on March 1, 2014, the third anniversary of the grant date.
- F11The options became fully exercisable on March 5, 2016, the third anniversary of the grant date.
- F12The options became fully exercisable on March 4, 2017, the third anniversary of the grant date.
- F13One-third of the options became exercisable on March 3, 2016, an additional one-third of the options became exercisable on March 3, 2017 and the remaining one-third of the options will become exercisable on March 3, 2018, the third anniversary of the grant date.
- F14One-third of the options became exercisable on March 1, 2017, an additional one-third of the options became exercisable on March 1, 2018 and the remaining one-third of the options will become exercisable on March 1, 2019, the third anniversary of the grant date.
- F15One-third of the options became exercisable on February 28, 2018, an additional one-third of the options will become exercisable on February 28, 2019 and the remaining one-third of the options will become exercisable on February 28, 2020, the third anniversary of the grant date.
- F2Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $54.82 to $54.84 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $53.86 to $54.78 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $53.83 to $54.80 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5Transaction involving a disposition to the Company of equity securities to cover tax withholding obligations arising from the performance share certification reported on a Form 4 dated February 21, 2018, in accordance with the Company's administrative rules.
- F6The closing price of the Company's common stock on February 21, 2018, the day of certification.
- F7Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $53.82 to $54.81 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8One-third of the options will become exercisable on February 27, 2019, an additional one-third of the options will become exercisable on February 27, 2020 and the remaining one-third of the options will become exercisable on February 27, 2021, the third anniversary of the grant date.
- F9The options became fully exercisable on February 28, 2015, the third anniversary of the grant date.
Remarks
cdpoaforct.txt